<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00245</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (v) Lungs and trachea of the whole-body perfusion-fixed test  <!-- PJG 0012 frnewline --> animals cited in paragraph (d)(1)(ii)(A) of this section are  <!-- PJG 0012 frnewline --> examined for inhaled particle distribution.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (e) Interpretation of results. All observed results,  <!-- PJG 0012 frnewline --> quantitative and incidental, shall be evaluated by an appropriate  <!-- PJG 0012 frnewline --> statistical method. The specific methods, including  <!-- PJG 0012 frnewline --> consideration of statistical power, shall be selected during the  <!-- PJG 0012 frnewline --> design of the study.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (f)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test report. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In addition to the reporting requirements  <!-- PJG 0012 frnewline --> as specified under &sect;&sect;79.60 and 79.61(e), the following  <!-- PJG 0012 frnewline --> individual animal data information shall be reported:  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (1) Date of death during the study or whether animals  <!-- PJG 0012 frnewline --> survived to termination.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (2) Date of observation of each abnormal sign and its  <!-- PJG 0012 frnewline --> subsequent course.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (3) Individual body weight data, and group average body  <!-- PJG 0012 frnewline --> weight data vs. time.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (4) Feed consumption data, when collected.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (5) Hematological tests employed and all results.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (6) Clinical biochemistry tests employed and all results.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (7) Necropsy findings.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (8) Type of stain/fixative and procedures used in preparing  <!-- PJG 0012 frnewline --> tissue samples.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (9) Detailed description of all histopathological findings.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (10) Statistical treatment of the study results, where  <!-- PJG 0012 frnewline --> appropriate.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (g)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> References. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  For additional background information on  <!-- PJG 0012 frnewline --> this test guideline, the following references should be  <!-- PJG 0012 frnewline --> consulted.  <!-- PJG 0012 frnewline -->  (1) 40 CFR 798.2450, Inhalation toxicity.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (2) 40 CFR 798.2675, Oral Toxicity with Satellite  <!-- PJG 0012 frnewline --> Reproduction and Fertility Study.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (3) General Statement of Work for the Conduct of Toxicity  <!-- PJG 0012 frnewline --> and Carcinogenicity Studies in Laboratory Animals (revised April,  <!-- PJG 0012 frnewline --> 1987/modifications through January, 1990) appendix G, National  <!-- PJG 0012 frnewline --> Toxicology Program_U.S. Dept. of Health and Human Services  <!-- PJG 0012 frnewline --> (Public Health Service), P.O. Box 12233, Research Triangle Park,  <!-- PJG 0012 frnewline --> NC 27709.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;79.63  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Fertility assessment/teratology.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Purpose. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Fertility assessment/teratology is an  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> in vivo <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline --> study designed to provide information on potential health hazards  <!-- PJG 0012 frnewline --> to the fetus arising from the mother's repeated inhalation  <!-- PJG 0012 frnewline --> exposure to vehicle/engine emissions before and during her  <!-- PJG 0012 frnewline --> pregnancy. By including a mating of test animals, the study  <!-- PJG 0012 frnewline --> provides preliminary data on the effects of repeated  <!-- PJG 0012 frnewline --> vehicle/engine emissions exposure on gonadal function,  <!-- PJG 0012 frnewline --> conception, and fertility. Since this is a one-generation test  <!-- PJG 0012 frnewline --> that ends with examination of full-term fetuses, but not of live  <!-- PJG 0012 frnewline --> pups, it is not capable of determining effects on reproductive  <!-- PJG 0012 frnewline --> development which would only be detected in viable offspring of  <!-- PJG 0012 frnewline --> treated parents.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (b)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Definitions. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  For the purposes of this section, the  <!-- PJG 0012 frnewline --> following definitions apply:  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Developmental toxicity <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  means the ability of an agent to induce  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> in  <!-- PJG 0012 frnewline --> utero <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  death, structural or functional abnormalities, or growth  <!-- PJG 0012 frnewline --> retardation after contact with the pregnant animal.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Estrous cycle <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  means the periodic recurrence of the biological  <!-- PJG 0012 frnewline --> phases of the female reproductive system which prepare the animal  <!-- PJG 0012 frnewline --> for conception and the development of offspring. The phases of  <!-- PJG 0012 frnewline --> the estrous cycle for a particular animal can be characterized by  <!-- PJG 0012 frnewline --> the general condition of the cells present in the vagina and the  <!-- PJG 0012 frnewline --> presence or absence of various cell types.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            